首页 | 本学科首页   官方微博 | 高级检索  
检索        

COX-2和VEGF-C表达与NSCLC淋巴转移的关系
引用本文:丁旭青,杨鲲鹏,王旭广,郭亮,孙新超.COX-2和VEGF-C表达与NSCLC淋巴转移的关系[J].河南外科学杂志,2007,13(3):1-2.
作者姓名:丁旭青  杨鲲鹏  王旭广  郭亮  孙新超
作者单位:1. 郑州大学第二附属医院胸外科,450014
2. 河南省南阳市第二人民医院病理科
摘    要:目的探讨环氧化酶-2(COX-2)和血管内皮生长因子-C(VEGF-C)表达与淋巴管形成和淋巴结转移之间的关系。方法用免疫组化链霉素抗生物素蛋白-过氧化物酶(SP)法检测65例非小细胞肺癌(NSCLC)及16例正常肺组织中COX-2、VEGF-C及其受体VEGFR-3的表达;以VEGFR-3作标记计数肿瘤LVD,并结合临床病理特征进行统计学分析。结果65例NSCLC中COX-2和VEGF-C表达阳性率分别为76.9%(50/65)、72.3%(47/65)。COX-2表达与淋巴结转移(r=0.489,P<0.01)、临床分期(r=0.354,P<0.05)、VEGF0C(r=0.640,P<0.01)和LVD(r=0.518,P<0.01)呈正相关,而与病理分化程度呈负相关(r=-0.427,P<0.01)。VEGF-C表达与淋巴结转移(r=0.453,P<0.01)、临床分期(r=0.442,P<0.01)和LVD(r=0.624,P<0.01)呈正相关,与病理分化程度也呈负相关(r=-0.525,P<0.01)。结论NSCLC中COX-2与VEGF-C均高表达,COX-2可能通过VEGF-C促进肿瘤淋巴管生成和淋巴结转移。研究COX-2和VEGF-C在肿瘤中的协同作用有助于揭示肿瘤侵袭和转移的机制。

关 键 词:环氧化酶-2  血管内皮生长因子-C  VEGF-C  淋巴管生成  非小细胞肺癌  免疫组织化学
收稿时间:2007-02-16
修稿时间:2007年2月16日

Expression of COX-2 and VEGF-C and their correlation with lymphatic metastasis in NSCLC
DING Xuqing,YANG Kunpeng,WANG Xuguang,GUO Liang,SUN Xinchao.Expression of COX-2 and VEGF-C and their correlation with lymphatic metastasis in NSCLC[J].Henan JOurnal of Surgery,2007,13(3):1-2.
Authors:DING Xuqing  YANG Kunpeng  WANG Xuguang  GUO Liang  SUN Xinchao
Abstract:Objective To investigate the expression of COX-2 and VEGF-C and their correlation with lymphangiogenesis and lymph node metastasis in lung cancer.Methods The expression of COX-2,VEGF-C and their receptor,VEGFR-3 was detected in 65 patients with NSCLC and 16 normal pulmonary tissue specimens by immunohistochemical staining SP method.The lymphatic vessel density(LVD)in tumor was counted by VEGFR-3and analyzed with clinicopathologic parameters. Results The positive rate of COX-2 and VEGF-C was positively correlated with lymphatic node metastasis (r=0.489,P<0.01),clinical stage(r=0.354,P<0.05),VEGF-C(r=0.640,P<0.01)and LVD(r=0.518,P<0.01),but was negatively correlated with pathologic differentiation(r=0.427,P<0.01).The expression of VEGF-C was positively correlated with lymph node metastasis (r=0.354,P<0.01),clinical stage(r=0.442,P<0.05),LVD(r=0.624,P<0.01),and also negatively correllated with pathologic differentiation (r=0.525,P<0.01).Conclusion High expression of COX-2 and VEGF-C exist in NSCLC. COX-2 may stimulate lymphangiogenesis and lymphatic metastasis via VEGF-C, Study of their ynteraction will enormousely promote to discover mechanisms of tumorous invasion and metastasis.
Keywords:COX-2  VEGF-C  Lymphangiogenesis  NSCLC  Imunohemistry
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号